Loading…
← CockpitCompetitor Analysis › 002790.KS AMOREPACIFIC HoldingsOpen in the cockpit ↗

AMOREPACIFIC Holdings002790.KSCompetitor analysis, valuation and peers

South Korea · KRW·Consumer Staples›Household/Personal Care

Holding company atop Amorepacific Corp, Korea's top cosmetics maker behind Sulwhasoo, Innisfree and Laneige.

Momentum leader 86
Mkt cap
$1.55B
US dollars, full cap
Free float
33%
of shares outstanding
$/day
$2.06M
20-day average traded
Fwd P/E
8.4×
forward earnings
ROIC−WACC
-0.8 pp
WACC 5.3%
Hurdle
-17 pp
Req g minus delivered
Next earnings
97 days
11 Feb 2027
Close · KRW₩27,100
1D-1.6%
1W+6.7%
1M+2.3%
3M+4.6%
6M-2.7%
YTD+2.3%
1Y+8.8%
ATR %4.2%
52w lowhigh23.6% off high

What AMOREPACIFIC does

Holding company atop Amorepacific Corp, Korea's top cosmetics maker behind Sulwhasoo, Innisfree and Laneige.

Holds shares in Amorepacific Corp and other group companies, so its own income is dividends and brand-royalty payments from them, and its consolidated results largely mirror the operating company. Created in 2007 when the group split into a holding company and an operating company, and controlled by the founding Suh family.

Products and services

  • Amorepacific Corp stake
  • Other group affiliates

Where it sits in the supply chain

  • Consumer holding company
  • Cosmetics/beauty group
  • Group holding structure

What could go right

  • Amorepacific Corp brand recovery (Laneige, Sulwhasoo)

What could go wrong

  • Holding-company discount
  • China/duty-free demand swings at subsidiary

Moat: none. Pure holding company; value depends on operating subsidiary Amorepacific Corp.

Headquarters: Seoul, South Korea · Founded: 2006 · Employees: 60

Named competitors

AMOREPACIFIC at a glance

Size AMOREPACIFIC (002790.KS) is a South Korea Consumer Staples company (Household/Personal Care) with a market value of $1.55B, the 161st largest of 495 South Korea companies the cockpit tracks. Shares closed at ₩27,100 on 6 Nov 2026.

Performance Over six months the shares fell 2.7%, against -2.0% for the median peer and -24.5% for the South Korea market (cap-weighted) — 11th highest of 21 in its peer set.

Growth Revenue grew 8.6% over the last twelve months (peer median +5.0%); the operating margin is 9.0% (peer median 9.8%).

Valuation It trades at 8.4× forward earnings against a peer median of 20.3× (2nd cheapest of 21).

Price implies For today's price to make sense, revenue must grow about -18% a year for seven years (Req g). Recent delivered growth is -1%, so the hurdle is -17 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 0.8 points below its cost of capital (5.3% WACC).

Next results Next results expected around 11 Feb 2027 (exchange calendar; dates can move).

Relative performance

8010011 May 202611 Aug 20266 Nov 2026Peer median 100002790.KS 95
Six months, rebased to 100: AMOREPACIFIC against the median of its 20 peers (local-currency closes).

AMOREPACIFIC financials

Reported figures in KRW; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue₩4.94T₩4.62T₩4.26T₩4.02T₩4.49T
Revenue growth—+9%+6%-11%—
Gross profitn/a₩3.13T₩2.87T₩2.67T₩2.91T
EBITDAn/a₩648B₩517B₩411B₩595B
Net income₩173B₩104B₩230B₩119B₩62.2B
Free cash flown/a₩553B₩297B₩202B₩63.8B
Capital expendituren/a₩107B₩117B₩232B₩160B
Total debtn/a₩346B₩452B₩374B₩367B

Quarterly statements and history in the cockpit →

AMOREPACIFIC competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-40%-20%0%+20%-20%0%301371ICOS003006ENR6039837956600315EMAMILTD483650300957EPC699316189049272145192820492226982657PGHH002790.KS6-month return →1-month return →
Up and to the right = strong over both horizons. AMOREPACIFIC is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%+60%10×20×30×40×301371ICOS003006ENR6039837956600315EMAMILTD483650EPC699316189049272145192820492226982657PGHH002790.KSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. AMOREPACIFIC is the large dot.

Capital: growth delivered against growth the price implies

-20%0%+20%+40%-20%0%20%40%301371ICOS003006ENR7956600315EMAMILTD483650300957EPC1618904927214526982657PGHH002790.KSGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. AMOREPACIFIC is the large dot.

AMOREPACIFIC competitors and peer comparison

Head to head with its named competitors (002790.KS vs 051900.KS)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
AMOREPACIFIC 002790.KS$1.55B-3%+9%9%8.4×-17.9%
LG H&h 051900.KS$2.56B-8%-3%3%18.5×-0.1%

How AMOREPACIFIC compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

AMOREPACIFIC against its 20 peers (data as of 6 Nov 2026)
Measure002790.KSPeer medianRank in peer set
1-month return+2.3%+2.0%11th highest of 21
6-month return-2.7%-2.0%11th highest of 21
Distance from 52-week high-23.6%-31.5%9th highest of 21
Revenue growth (TTM)+8.6%+5.0%9th highest of 21
Operating margin9.0%9.8%10th lowest of 21
Forward P/E8.4×20.3×2nd cheapest of 21
Growth the price implies (Req g, 7 yrs)-17.9%4.5%least demanding of 17
Growth delivered (Del g)-1.3%+9.5%2nd lowest of 17
Hurdle (Req g minus delivered)-16.6 pp-4.9 pp4th least demanding of 17
ROIC minus cost of capital-0.8 pp+6.5 pp6th lowest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
AMOREPACIFIC 002790.KSSouth Korea$1.55B-3%+9%9%8.4×-17.9%-1.3%
Harbin Fuerjia Technology 301371.SZChina$1.58B-30%+28%20%22.5×8.7%+3.6%
Intercos ICOS.MIItaly$1.50B+16%-5%9%19.5×4.5%+11.5%
Chongqing Baiya Sanitary Products 003006.SZChina$1.49B+25%0%3%41.2×30.6%+22.8%
Energizer ENRUnited States$1.63B+26%+2%16%7.2×-5.2%+1.5%
Guangdong Marubi Biotechnology 603983.SSChina$1.45B-4%-6%2%37.0×n/an/a
Pigeon 7956.TJapan$1.66B+30%+7%13%26.3×-1.3%+1.9%
Shanghai Jahwa United 600315.SSChina$1.74B-13%+9%2%18.1×17.1%-2.1%
Emami EMAMILTD.NSIndia$1.80B-15%+3%20%21.4×21.7%+5.6%
d'Alba Global 483650.KSSouth Korea$1.32B-37%+55%21%13.6×-2.2%+53.0%
Yunnan Botanee Bio-Technology 300957.SZChina$1.84B-28%+7%9%21.2×4.5%+15.3%
Edgewell Personal Care EPCUnited States$1.29B+32%-7%6%12.4×4.1%+2.7%
Blue Moon 6993.HKHong Kong$1.88B-15%-2%-2%93.6×n/an/a
Kolmar Korea 161890.KSSouth Korea$1.89B+23%+13%10%13.0×-0.9%+15.5%
Pola Orbis 4927.TJapan$1.96B+8%+1%10%28.8×-3.1%-0.7%
Shanghai Chicmax Cosmetics 2145.HKHong Kong$1.22B-52%+23%8%15.0×-5.9%+21.2%
Cosmax 192820.KSSouth Korea$2.13B+21%+16%8%16.6×n/an/a
KOSE 4922.TJapan$2.16B+7%+3%4%27.2×n/an/a
Softcare 2698.HKHong Kong$2.20B-5%+25%25%14.4×8.7%+20.9%
Shanghai Forest Cabin Cosmetics 2657.HKHong Kong$1.06B0%+74%18%12.1×11.5%+49.0%
Procter & Gamble Hygiene & Health Care PGHH.NSIndia$2.40B-29%-2%24%27.3×15.4%+7.4%

Questions

Who are AMOREPACIFIC's main competitors?
Named competitors: LG H&H (051900.KS). The cockpit's measured peer set (industry) also includes Harbin Fuerjia Technology (301371.SZ), Intercos (ICOS.MI), Chongqing Baiya Sanitary Products (003006.SZ), Energizer (ENR), Guangdong Marubi Biotechnology (603983.SS), Pigeon (7956.T).
Is AMOREPACIFIC expensive compared with its peers?
On forward p/e it trades at 8.4× against a peer median of 20.3×, 2nd cheapest of 21 in its peer set. For today's price to make sense, revenue must grow about -18% a year for seven years (Req g). Recent delivered growth is -1%, so the hurdle is -17 pp: the price already allows for a slowdown.
How has AMOREPACIFIC stock performed?
Over six months to 6 Nov 2026 the shares returned -2.7% against -2.0% for the median peer; over one year +8.8%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.